Browse
Explore conditions, clinical trials, and the organisations running them.
Up to: Acute leukemia · Myeloid leukemia
Acute myeloid leukemia
Acute myeloid leukemia (AML) is a group of neoplasms arising from precursor cells committed to the myeloid cell-line differentiation. All of them are characterized by clonal expansion of myeloid blasts. AML manifests by fever, pallor, anemia, hemorrhages and recurrent infections.
-
Acute leukemia of ambiguous lineage 53 trials · 145 incl. sub-types Sub-types →
-
Therapy related acute myeloid leukemia and myelodysplastic syndrome 87 trials · 88 incl. sub-types Sub-types →
-
Acute myeloid leukemia by FAB classification 0 trials · 59 incl. sub-types Sub-types →
-
Acute myeloid leukemia with mutated NPM1 25 trials
-
Inherited acute myeloid leukemia 1 trial · 25 incl. sub-types Sub-types →
-
Childhood acute myeloid leukemia 24 trials
-
Acute monocytic leukemia 20 trials Sub-types →
-
Acute myeloid leukemia with BCR-ABL1 7 trials
-
Acute myeloid leukemia, Monosomy 5 0 trials
-
Acute myeloid leukemia, Monosomy 7 0 trials
-
Acute myeloid leukemia, Trisomy 8 0 trials
-
Acute myeloid leukemia, der12p 0 trials
-
Acute myeloid leukemia, t(11;17) 0 trials
-
Acute myeloid leukemia, t(1;22) 0 trials
-
Acute myeloid leukemia, t(2;12) 0 trials
-
Acute myeloid leukemia, t(8;16) 0 trials